Evidence map›Paper›PMID 41955519›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Methylglyoxal Accumulation is Associated with Brain Inflammation after Myocardial Infarction with Sex and Regional Differences.

Ramis Ileri, Xixi Guo, Erik J Suuronen

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Heart Meets Brain: Insights into Neurocardiac Pathophysiology.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ramis IleriBioengineering and Therapeutic Solutions (BEaTS) Program, University of Ottawa Heart Institute, Ottawa, Canada.
Xixi GuoBioengineering and Therapeutic Solutions (BEaTS) Program, University of Ottawa Heart Institute, Ottawa, Canada.
Erik J SuuronenBioengineering and Therapeutic Solutions (BEaTS) Program, University of Ottawa Heart Institute, Ottawa, Canada.ORCID https://orcid.org/0000-0002-6470-060X

Funding

CIHR PJT-183748
6 · The paper itself

Abstract

Patients with myocardial infarction (MI) have an increased risk of developing neurological disease and cognitive impairment, but the mechanisms underlying the heart-brain interaction remain to be better elucidated. Methylglyoxal (MG), a highly reactive dicarbonyl, is a shared causative factor associated with cardiovascular and neurological diseases. MG-derived advanced glycation end products (MG-AGEs) accumulate in the heart and circulation post-MI, making it a promising target in studying the heart-brain axis. Here, we report that MG-AGEs accumulate in the mouse brain at 6 h and 7 days post-MI, with the highest expression observed in the brainstem, followed by the cortex. Notably, males had higher MG-AGE expression compared to females in most brain regions. The accumulation of MG-AGEs in the brain was correlated with increased neuroinflammation, including a greater number of activated microglia and macrophages, and increased expression of AGE receptors. Greater inflammatory factor expression (NF-κB and TNF-α) and a reduction in tight junction proteins of the blood brain barrier were also observed. Taken together, this study reveals a novel MG-mediated mechanism with sex-based differences that may contribute significantly to heart-brain interactions after MI and identifies a promising therapeutic target for treating the neurological impairment associated with heart disease.

Indexed as

BrainEncephalitisGlycation End Products, AdvancedMyocardial InfarctionPyruvaldehydeAnimalsDisease Models, AnimalFemaleMaleMiceMice, Inbred C57BLMicrogliaSex FactorsGlycation End Products, AdvancedPyruvaldehydeheart‐brain interactionmethylglyoxalmyocardial infarctionsex differences

Identifiers

PMID41955519
PMCPMC13334616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.